Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection-Reference-Cited by-同舟云学术

Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection

Published:2014-12-08 Issue:12 Volume:9 Page:e114410
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

García-Quintanilla Meritxell,Pulido Marina R.,Pachón Jerónimo,McConnell Michael J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Isolation of Acinetobacter from soil and water;P Baumann;J Bacteriol,1968

2. García-Quintanilla M, Pulido MR, McConnell MJ (2013) First Steps Towards a Vaccine Against Acinetobacter baumannii. Curr Pharm Biotechnol. In press.

3. Acinetobacter infection;LS Muñoz-Price;N Engl J Med,2008

4. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii;PL Ho;Chest,2009

5. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific;CW Ong;Respirology,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of Lipooligosaccharide Synthesis in Acinetobacter baumannii Produces Changes in Outer Membrane Vesicle Protein Content;International Journal of Molecular Sciences;2024-08-27

2. Inserting Omp22 into the flagellin protein, replacing its hypervariable region, results in stronger protection against sepsis caused by Acinetobacter baumannii in a mouse model;2024-08-14

3. Extensively and multidrug-resistant bacterial strains: case studies of antibiotics resistance;Frontiers in Microbiology;2024-07-04

4. Development and Evaluation of an Immunoinformatics-Based Multi-Peptide Vaccine against Acinetobacter baumannii Infection;Vaccines;2024-03-27

5. Acinetobacter baumannii;Molecular Medical Microbiology;2024